Improving the selective neonatal BCG program

Area of Science:

• Public Health
• Vaccinology
• Neonatal Care

Background:

• Tuberculosis (TB) remains a significant global health concern, necessitating effective prevention strategies in neonates.
• Existing neonatal Bacille-Calmette-Guerin (BCG) vaccination programs face challenges in implementation and reach.
• Targeted vaccination approaches are crucial for optimizing resource allocation and impact.

Purpose of the Study:

• To develop and implement an enhanced selective neonatal BCG vaccination program.
• To systematically identify and prioritize neonates at high risk of tuberculosis exposure.
• To improve the efficiency and effectiveness of neonatal BCG vaccine delivery.

Main Methods:

• Evaluation of existing national service models for neonatal BCG vaccination.
• Consideration of limitations and challenges associated with different service delivery approaches.
• Implementation of a selective neonatal BCG program incorporating universal neonatal screening for risk assessment.

Main Results:

• The development of the new neonatal BCG service encountered anticipated obstacles, with strategies for overcoming them detailed.
• Preliminary data indicate positive outcomes regarding the service model's implementation.
• Neonatal BCG uptake rates within the selective program were encouraging.

Conclusions:

• A successful and improved selective neonatal BCG vaccination program was implemented.
• The developed program offers a potentially scalable and effective model for tuberculosis prevention in newborns.
• The findings suggest that systematic risk assessment can enhance the impact of neonatal BCG vaccination efforts.